| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Sarah J Stock | Q87661010 |
| P2093 | author name string | Jane E Norman | |
| P2860 | cites work | Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? | Q26996499 |
| Review of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act: What can the obstetric community learn from the pediatric experience? | Q28083836 | ||
| Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review | Q28109657 | ||
| Medication use in pregnancy: a cross-sectional, multinational web-based study | Q30572132 | ||
| Data resources for investigating drug exposure during pregnancy and associated outcomes: the General Practice Research Database (GPRD) as an alternative to pregnancy registries | Q31140627 | ||
| Market failure and the poverty of new drugs in maternal health | Q33316160 | ||
| Prolonged exposure to acetaminophen reduces testosterone production by the human fetal testis in a xenograft model | Q34044061 | ||
| Current perspective of diethylstilbestrol (DES) exposure in mothers and offspring | Q34556109 | ||
| Designing drug trials: considerations for pregnant women | Q34999905 | ||
| Prescription drug use during pregnancy in developed countries: a systematic review | Q36176863 | ||
| Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach | Q36263475 | ||
| Use of health care databases in pharmacoepidemiology | Q36447538 | ||
| Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. | Q37222764 | ||
| Systematic analysis of research underfunding in maternal and perinatal health | Q37383543 | ||
| Obstetric Pharmacokinetic Dosing Studies are Urgently Needed | Q37575742 | ||
| Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk | Q37718640 | ||
| Drugs dispensed in primary care during pregnancy: a record-linkage analysis in Tayside, Scotland. | Q37765551 | ||
| The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. | Q37874439 | ||
| Evolving knowledge of the teratogenicity of medications in human pregnancy. | Q37902132 | ||
| Exclusion of pregnant women from industry-sponsored clinical trials | Q38150667 | ||
| Accelerating the paradigm shift toward inclusion of pregnant women in drug research: Ethical and regulatory considerations | Q38589291 | ||
| From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources | Q38608709 | ||
| The pregnant women as a drug orphan: a global survey of registered clinical trials of pharmacological interventions in pregnancy. | Q38853715 | ||
| Improving Safe and Effective Use of Drugs in Pregnancy and Lactation: Workshop Summary. | Q38988661 | ||
| Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population | Q44414995 | ||
| The Nordic medical birth registers--a potential goldmine for clinical research | Q46318319 | ||
| SemEHR: A general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research. | Q47552792 | ||
| The hope, hype and reality of Big Data for pharmacovigilance | Q47561263 | ||
| Medication use during pregnancy | Q47820140 | ||
| Women are unaware of pregnancy risks linked with sodium valproate | Q50480439 | ||
| Drug prescribing during pregnancy in a central region of Italy, 2008-2012. | Q55381650 | ||
| Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy | Q57036011 | ||
| Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink | Q57293592 | ||
| β-Blocker Use in Pregnancy and the Risk for Congenital Malformations: An International Cohort Study | Q57455598 | ||
| Systematic Identification of Drugs That Cause Birth Defects — A New Opportunity | Q60727536 | ||
| Adherence to medication for chronic disorders during pregnancy: results from a multinational study | Q86594702 | ||
| Risk perception regarding drug use in pregnancy | Q89004542 | ||
| New regulations to cut valproate-exposed pregnancies | Q91059260 | ||
| Trophoblast organoids as a model for maternal-fetal interactions during human placentation | Q93382238 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P921 | main subject | health care | Q31207 |
| pregnant women | Q308623 | ||
| pharmacotherapy | Q701216 | ||
| P577 | publication date | 2019-06-20 | |
| P1433 | published in | F1000Research | Q27701587 |
| P1476 | title | Medicines in pregnancy | |
| P478 | volume | 8 |
| Q92074895 | The Innovative Medicines Initiative -10 Years of Public-Private Collaboration | cites work | P2860 |
Search more.